GGrantIndex
Sort

53,477 grants matching addiction

Biological And Biochemical Characterization Of Sigma Receptors

$1,159,161
Tsung-Ping Ping Su · National Institute On Drug Abuse · ZIA · FY2017 · DA

Biological And Biochemical Characterization Of Sigma Receptors

$1,159,128
Tsung-Ping Ping Su · National Institute On Drug Abuse · ZIA · FY2010 · DA

Efficacy/Effectiveness of Unhealthy Drug Use Screening/Brief Intervention Models

$1,158,668
Richard Saitz · Boston Medical Center · R01 · FY2009 · DA

Medicinal Chemistry of Drugs Acting on Central and Peripheral Opioid Receptors

$1,158,393
Kenner Rice · National Institute On Drug Abuse · ZIA · FY2014 · DA

Comparative Analysis of Genetics of Stress Response and Reward

$1,158,262
Christina Barr · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2014 · AA

Implementation of telemedicine and social network driven HIV service uptake for comprehensive HIV service integration in rural syringe service programs

$1,158,132
Oluwaseun Falade-Nwulia · Johns Hopkins University · R01 · FY2024 · DA

Reversing Overdose Epidemics through Simulation, Collaboration, and Unified Efforts (RESCUE)

$1,158,064
Xiao Zang · University Of Minnesota · R33 · FY2024 · DA

NOVEL PHARMACOTHERAPIES FOR COCAINE DEPENDENCE

$1,157,895
New York State Psychiatric Institute · P50 · FY2002 · DA

VACCINATION FOR TREATMENT OF NICTOTINE DEPENDENCE

$1,157,646
Nabi Biopharmaceuticals · U19 · FY2003 · DA

Basic Dopamine Transporter Mechanisms Of Cocaine

$1,156,701
Jonathan L Katz · National Institute On Drug Abuse · Z01 · FY2008 · DA

Biological And Biochemical Characterization Of Sigma Receptors

$1,156,519
Tsung-Ping Ping Su · National Institute On Drug Abuse · ZIA · FY2018 · DA

Maternal Opioid Treatment: Human Experimental Research

$1,156,470
Hendree E. Jones · Johns Hopkins University · R01 · FY2007 · DA

Medication Discovery Using Rat Models of Relapse. Period of Performance: 7/10/2019-7/9/2021. N01DA-19-8949

$1,156,293
Virginia Commonwealth University · N01 · FY2020 · DA

MEDICATION DEVELOPMENT UNIT FOR STIMULANT DEPENDENCE

$1,156,279
Friends Research Institute, Inc. · P50 · FY2000 · DA

A multi-team system implementation strategy to improve buprenorphine adherence for patients who initiate treatment in the emergency department

$1,156,200
Stephen G Henry · University Of California At Davis · R33 · FY2025 · DA

Florida Node Alliance of the Drug Abuse Clinic Trials Network

$1,155,588
Jose Szapocznik · University Of Miami School Of Medicine · U10 · FY2011 · DA

Implementation of telemedicine and social network driven HIV service uptake for comprehensive HIV service integration in rural syringe service programs

$1,155,553
Oluwaseun Falade-Nwulia · Johns Hopkins University · R01 · FY2025 · DA

Hypothalamic neuronal circuits controlling goal-directed behaviors

$1,155,381
Yexica Aponte Moreno · National Institute On Drug Abuse · ZIA · FY2015 · DA

Appalachian Node

$1,155,212
Jane M Liebschutz · University Of Pittsburgh At Pittsburgh · UG1 · FY2020 · DA

Integrating Addiction and Infectious Diseases Services into Primary Care in Rural Settings

$1,155,157
Frederick Lewis Altice · Yale University · R01 · FY2023 · DA

Clinical Trials Network, Ohio Valley Node U10DA013732

$1,154,837
T John Winhusen · University Of Cincinnati · U10 · FY2013 · DA

Clinical Trials Network, Ohio Valley Node U10DA013732

$1,154,735
T John Winhusen · University Of Cincinnati · U10 · FY2012 · DA

Novel 5-HT2A/mGluR5 Antagonist for Opioid Use Disorder

$1,153,945
Frederick Gerard Moeller · Virginia Commonwealth University · UG3 · FY2025 · DA

Clinical Trials Network: New Mexico Node

$1,153,931
Michael Parks Bogenschutz · University Of New Mexico · U10 · FY2006 · DA

Stress and Addiction Neuroscience Unit

$1,153,510
Leandro Vendruscolo · National Institute On Drug Abuse · ZIA · FY2023 · DA